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Abstract  24 
West Nile virus (WNV) is a zoonotic pathogen which is maintained in an enzootic cycle between 25 
mosquitoes and birds; humans, equines, other mammals and some bird species are dead-end hosts. 26 
Lineage 1 WNV strains have predominated in Europe since the 1960’s. However, in 2004 lineage 2 27 
strains emerged in Hungary and Russia, respectively, spreading since then to a number of 28 
neighbouring countries (e.g., Austria, Greece, Italy, Serbia and Romania). Wild bird mortality is a 29 
hallmark of North American WNV outbreaks, a feature uncommon in Europe. This study aimed to 30 
compare the course of infection of lineage 1 (NY99) and lineage 2 (Austria/2008) WNV strains in 31 
the house sparrow, a bird species common in Europe and North America. House sparrows were 32 
inoculated with either NY99 or Austria/2008 WNV strains, or sham-inoculated, and clinical and 33 
analytic parameters (viraemia, viral load, antibodies) were examined until 14 days after inoculation. 34 
Although all inoculated sparrows became infected, no mortality or clinical signs were observed due 35 
to the infection. However, the magnitude and duration of viraemia were higher for NY99- than for 36 
Austria/2008- infected birds. The house sparrow proved to be a competent host for both strains, 37 
although the competence index calculated for NY99 was higher than for Austria/2008. Viral load in 38 
tissues and swabs was also higher in NY99-inoculated sparrows. In conclusion, the house sparrow is 39 
a convenient avian model for studying host competence of WNV strains. The observed differences 40 
between NY99 and Austria/2008 strains might have important epidemiological consequences for 41 
disease incidence and dispersal capacity.   42 
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 47 
1. Introduction 48 
West Nile virus (WNV, family Flaviviridae, genus Flavivirus) is an neurotropic arbovirus affecting 49 
man, horses and birds, that is maintained in an enzootic cycle between mainly Culex mosquito 50 
vectors and birds acting as primary vertebrate hosts (Work et al., 1955). Two major genetic lineages, 51 
1 and 2 (hereafter L1 and L2, respectively) are phylogenetically distinguishable. In North America, 52 
all circulating strains have been derived from a single introduction of L1, first detected in 1999 (type 53 
strain: NY99)(Lanciotti et al., 1999). North American outbreaks are characterized by wild bird 54 
mortality and high pathogenicity for humans and horses (Komar et al., 2003, 2001). In Europe, 55 
where WNV is known since the 1960s (Calistri et al., 2010), this virus was absent for nearly three 56 
decades and reemerged in the 1990s. Since then, several outbreaks of different magnitudes have 57 
occurred, mostly caused by strains belonging to L1 (Calistri et al., 2010). The first European L2 58 
strains of WNV were reported in 2004 in Hungary (Bakonyi et al., 2006) and in Southern Russia 59 
(Platonov et al., 2008). Subsequently, L2 strains were detected in Austria (Bakonyi et al., 2013; 60 
Wodak et al., 2011), Greece (Papa et al., 2011), Italy (Savini et al., 2012), Serbia (Petrović et al., 61 
2013), and Romania (Sirbu et al., 2011). The pathogenesis of L1 and L2 WNV strains has been 62 
compared experimentally only in gyrfalcons (Ziegler et al., 2013), but not in passerines, regarded as 63 
main amplifying hosts for WNV (Komar et al., 2003). The house sparrow (Passer domesticus) is an 64 
ubiquitous bird species, abundant in urban and peri-urban areas, being a competent host for WNV 65 
L1 (Komar et al., 2003). To date, no experimental study has been attempted to assess the infection 66 
potential and host capacity of house sparrows by WNV L2 strains, but recently it has been reported 67 
that house sparrows have been infected naturally with lineage 2 WNV in Hungary in 2009 (Bakonyi 68 
et al, 2013). This passerine species has become a model for the study of WNV infection in 69 
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susceptible avian hosts, which has been used to compare the course of infection of different WNV 70 
strains, including North American, Australian, African (Langevin et al., 2005) and European  (Del 71 
Amo et al., 2014) isolates, all belonging to L1. The present study aims to compare the course of 72 
infection of house sparrows experimentally infected with two WNV strains belonging to two 73 
different lineages, L1 (NY99, American origin) and L2 (Austria/2008, European origin).  74 
 75 
2. Materials and Methods 76 
2.1. Viruses and virus preparations 77 
WNV strains used in this work were: NY99-crow-V76/1 (obtained through the National Veterinary 78 
Service Laboratories, USDA, lot nº 034EDV0601), a North American WNV strain, isolated from a 79 
diseased crow during the WNV outbreak in New York in 1999 (GenBank accession nº FJ151394; 80 
hereafter NY99) and Austria/2008_gh, isolated from the brain of a goshawk found dead in Vienna, 81 
Austria in 2008  (Bakonyi et al., 2013)(GenBank accession nº KF179640; hereafter Austria/2008). 82 
All the above virus strains were propagated and titrated by plaque assays in Vero cells (ATCC CCL-83 
81). 84 
2.2. Birds and animal care 85 
Free-living house sparrows were captured using mist nets and banded in the province of Sevilla 86 
(Spain) in December, 2011. After a two months’ period of habituation to captivity in the Cañada de 87 
los Pájaros facilities (Sevilla), they were transported to the BSL-3 biocontainment facility at CISA 88 
(Valdeolmos, Spain) where they were bled to determine pre-existing immunity to WNV and housed 89 
in individual cages. The house sparrows (n=24) were randomly distributed in 3 groups of 8 90 
individuals, composed (whenever possible) of 50% males and 50% females. Mixed bird-seed and 91 
water were supplied ad libitum. All the animal care, handling and experimental procedures 92 
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performed in this work were supervised and approved by the National Committee for Ethics and 93 
Welfare in Animal Experimentation in Spain according to European legislation (Council Directive 94 
86/609/EEC). 95 
2.3. Experimental inoculation 96 
The inoculation was carried out essentially as described previously (Del Amo et al., 2014). Briefly, 97 
birds were inoculated subcutaneously in the neck with 0.1 ml of viral suspension containing 98 
approximately 10,000 plaque-forming units (pfu)/bird of NY99 WNV strain (n=8) or Austria/2008 99 
WNV strain (n=8). The control group (n=8), was sham-inoculated with an equivalent volume of 100 
diluent (DMEM plus antibiotics) and manipulated in the same way as the virus-inoculated birds. 101 
2.4. Clinical follow-up and collection of samples 102 
The experimental procedure was based on Sotelo et al. (Sotelo et al., 2011a), adapted to house 103 
sparrows as described (Del Amo et al., 2014), with some modifications, as follows: Clinical signs 104 
were monitored daily. Blood samples (0.1 ml obtained from the jugular vein) were collected at 1, 3, 105 
5, 7 and 9 days post-infection (dpi) from all birds to determine viraemia and viral loads. Similarly, 106 
oropharyngeal and cloacal swabs were collected from all birds one day before inoculation, and at 1, 107 
3, 5, 7 and 9 dpi. Blood samples were collected in sterile polypropylene tubes filled with 0.9 ml BA-108 
1 diluent as previously described (Sotelo et al., 2011a), mixed and stored at -70ºC until analysis. 109 
Swab samples were placed in sterile polypropylene tubes containing 1 ml PBS and immediately 110 
stored at -70ºC until analysis. Two birds per group were euthanized at 7 and 10 dpi. The remaining 111 
birds were euthanized at the end of the experiment (14 dpi) except one, from the Austria/2008-112 
inoculated group, which died at 7 dpi, likely as a consequence of manipulation during bleeding. 113 
Detailed necropsies were performed and tissue samples from brain, kidney, liver, heart and spleen 114 
were obtained from each individual and homogenized in PBS as described (Sotelo et al., 2011a). 115 
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Additional blood samples (0.1-0.2 ml/individual) were collected prior to inoculation and just before 116 
euthanasia, in order to obtain serum for antibody detection. 117 
2.5. Viraemia and viral load assays 118 
Viraemia and viral load were measured as previously described (Del Amo et al., 2014). Briefly, 119 
viraemia was measured by a standard plaque-formation assay in Vero cells, and viral load in blood, 120 
tissue samples and oropharyngeal and cloacal swabs was measured using a semi-quantitative real-121 
time RT-PCR method for the detection of L1 and L2 WNV genomes (Del Amo et al., 2013). 122 
Samples were considered positive in this test at Ct<40. 123 
2.6. Antibody detection assays 124 
Antibodies to WNV were detected in serum by a commercially available epitope-blocking ELISA 125 
(Ingezym West Nile Compac, INGENASA, Madrid, Spain) suitable for the detection of WNV 126 
antibodies in wild birds with low requirement of sample volume (Sotelo et al., 2011b). Neutralizing 127 
antibody titres were assessed by a standard virus-neutralization test (Sotelo et al, 2011b), using 128 
homologous virus as antigen. 129 
2.7. Calculation of host competence index (Ci) values 130 
The calculation of competence index values for the inoculated house sparrows was based on the 131 
formula described elsewhere (Komar et al., 1999), considering viraemia values above 105.0 pfu/mL as 132 
infectious for Culex pipiens mosquitoes (Turell et al., 2000). The duration of infectious viraemia (d) 133 
was calculated by interpolation of the points crossing the value y=105.0 pfu/mL in the viraemic curve. 134 
 135 
3. Results 136 
Neither mortality nor clinical signs were observed as a consequence of the infection of house 137 
sparrows with NY99 (L1) or Austria /2008 (L2) WNV. The mean peak viraemia was reached at 3 138 
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dpi in both inoculated groups, but house sparrows inoculated with NY99 strain developed higher 139 
virus titre and longer duration of the viraemic period than those inoculated with Austria/2008 (9.62 140 
log10 vs. 6.72 log10 and 8 vs. 6 days, respectively, Figure 1). The magnitude and duration of 141 
viraemia indicated that the house sparrow is a competent host for transmission of both NY99 and 142 
Austria/2008 WNV strains. However, the competence index (Ci) calculated for NY99 strain was 143 
2.09 whereas Ci was 0.60 for Austria/2008 strain (Table 1). All WNV-inoculated individuals 144 
seroconverted, as measured by ELISA, including those examined at 7 and 10 dpi. Neutralizing 145 
antibodies were detected in all NY99-inoculated individuals, with titres ranging from 1:20 to 1:80, 146 
and in birds inoculated with L2 Austria/2008 strain, with titres between 1:10 and 1:40. The sham-147 
inoculated (control) group, subjected to the same handling and sampling procedures as the 148 
inoculated groups, remained asymptomatic, seronegative and aviraemic during the whole 149 
experiment.   150 
In order to assess systemic infection and the extent of virus distribution in organs at different time 151 
points, two individuals from each group were euthanized at 7 and 10 dpi and the rest at 14 dpi. At 7 152 
dpi, one of the Austria/2008-inoculated birds (#22) died during manipulation and was also subjected 153 
to necropsy. This particular bird developed lower viraemia and the lowest viral loads in tissues, as 154 
shown in Table 2, suggesting altogether that it died as a consequence of the manipulation and not 155 
due to the infection. Viral load was determined in heart, liver, brain, kidney and spleen samples 156 
(Table 2). Overall, WNV infection was widely disseminated throughout the body, but birds 157 
inoculated with the NY99 strain reached higher viral loads (lower Ct) than those inoculated with the 158 
Austria/2008 strain, in all organs analyzed. Also, WNV RNA was more consistently detected in 159 
organ samples from individuals inoculated with NY99 (38 positives out of 40 tissue samples 160 
analyzed) than in those with Austria/2008 (22 positives out of 40 analyzed).  In general, viral 161 
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genome load in tissues declined over time, being higher at 7 dpi and then fading progressively at 10 162 
and 14 dpi. However, a significant variation between individuals was observed in this regard. For 163 
instance, in the group inoculated with Austria/2008, at 14 dpi, one individual (#20) still showed 164 
remarkable viral loads in all tissues, while others had almost (#19) or completely (#24) cleared the 165 
virus from the tissues examined. In kidney, the viral genome load remained slightly higher at the 166 
end of the experiment (14 dpi) than in the other organs, both in Austria/2008 and in NY99-167 
inoculated birds, though, again, individual variations were observed (Table 2). 168 
Assessment of viral genome shedding through the faecal and oral routes, yielded results consistent 169 
with those observed in blood and tissues: viral genome loads were higher, more persistent and more 170 
consistently detected in oropharyngeal and cloacal swabs from the group inoculated with the NY99 171 
strain than from the group inoculated with the Austria/2008 strain (Figure 2). Viral genome 172 
shedding in oral and cloacal swabs was detectable at 3 dpi in both groups. However, NY99-173 
inoculated birds were still shedding virus genome through both routes at 9 dpi, while virus genome 174 
shedding ceased at 5 dpi in the Austria/2008-inoculated birds (with the exception of one bird found 175 
positive orally at 7 dpi). 176 
4. Discussion 177 
The house sparrow is an abundant passerine species often sharing habitat with humans in urban and 178 
peri-urban locations. This species is distributed world-wide although its native range is restricted to 179 
the Palearctic. The house sparrow is susceptible to WNV infection and disease, and a competent 180 
host for virus transmission to blood-sucking mosquitoes (Komar et al., 2003; Nemeth et al., 2009, 181 
2008). Some important phenotypic traits of the virus, such as virulence, intensity of virus 182 
amplification and/or competence for virus transmission in this host can vary between different 183 
WNV strains (Del Amo et al., 2014; Langevin et al., 2005). In this context, it is worth mentioning 184 
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that up to now, approximately two-thirds of the experimental studies made on WNV infection in 185 
wild birds used the North American L1 type strain (NY99) (Pérez-Ramírez et al., 2014), and only 186 
few studies have focused on more recent Euro-Mediterranean WNV strains. To date, only two 187 
experimental studies have specifically addressed the course of infection of European L2 strains in 188 
wild birds, one using gyrfalcons (Ziegler et al., 2013) and another one using jackdaws (Lim et al, 189 
2014). Hence, the present paper is the first one reporting the outcomes of an experimental infection 190 
of house sparrows with a L2 WNV strain, and comparing the effects of infection by L1 and L2 virus 191 
strains in a passerine species.  192 
In the experimental design of the study it was considered important to include a reference strain to 193 
enable a comparison with other preceding studies. Strain NY99 was selected because it is the most 194 
commonly used strain in experimental studies in wild birds, including house sparrows. In these 195 
previous investigations, NY99 was found to be lethal for house sparrows in a range from 0% to 50% 196 
(0 to 38% in case of needle-inoculation) (Komar et al., 2003; Langevin et al., 2005; Lapointe et al., 197 
2009; Nemeth et al., 2009). In the present experiment NY99 did not cause any mortality, but in a 198 
recent study using identical experimental procedures, the same virus batch and house sparrows 199 
captured at the same location (Sevilla, Spain), 25% mortality was observed after infection with 200 
NY99 (Del Amo et al., 2014). Mortality rates in both experiments fall in the range already described 201 
but the differences observed deserve further discussion. First, they may just reflect random variation 202 
because these differences in mortality rate with respect to Del Amo et al. (2014) were not 203 
statistically significant (F-Fisher exact test, p=0.15), possibly due to the small sample size. Second, 204 
the birds used in our experiment were captured 5 months later than in (Del Amo et al., 2014), which 205 
might have caused a bias in the age of the birds employed. Birds’ age is known to be an important 206 
factor associated to host susceptibility (Pérez-Ramírez et al., 2014). Examination of plumage 207 
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characteristics additionally indicated that in the previous experiment the proportion of young birds 208 
was higher than in the present experiment. The relevance of age as a determinant factor in the 209 
susceptibility of the house sparrow to WNV disease has been proven in the study by Nemeth et al 210 
(2009), where differences in mortality were observed between adults (10%) and juveniles (23%) 211 
after inoculation with NY99 strain.  212 
Similarly to the NY99 L1 strain, the L2 strain Austria/2008 resulted in an asymptomatic infection in 213 
the house sparrow. Despite this, the experiment highlights several interesting differences between 214 
both strains: NY99 produced an enhanced virus amplification which yielded higher and longer 215 
viraemias, generated higher and more persistent viral loads in organs, and more intense, consistent 216 
and persistent virus genome shedding through the oral and cloacal routes, compared to the strain 217 
Austria/2008. Accordingly, the host competence index calculated for NY99 was also higher than for 218 
Austria/2008, which suggests that mosquito vectors feeding on NY99-infected house sparrows may 219 
acquire the infection more readily than if feeding on Austria/2008-infected ones. In other words, 220 
house sparrows infected with NY99 would transmit the virus much more efficiently and for longer 221 
periods than those infected with the Austria/2008 strain, not only through mosquito bites, but 222 
possibly also when preyed or scavenged by other animals, like raptors (Nemeth et al., 2009), since 223 
the virus lasted for longer periods also in their organs.  Despite seroconversion was observed in all 224 
house sparrows inoculated with either of the strains tested, a slightly lower (1:10-1:40 titre) 225 
neutralizing antibody response was detected in house sparrows of the group inoculated with the L2 226 
strain Austria/2008, with respect to the neutralizing antibody response observed in those inoculated 227 
with L1 (NY99), which was present in all  individuals of this group, with titres ranging from 1:20 to 228 
1:80. This slight difference in immunogenicity could be consistent with a less intense infection by 229 
WNV Austria/2008, compared with WNV NY99, as the other data from this paper already indicate. 230 
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In this study, the strain NY99 exceeded the amplification capacity of the L2 strain Austria/2008 in 231 
the house sparrow. This has also been observed for other L1 strains recently isolated in Southern 232 
Europe (Del Amo et al., 2014). Overall, it appears that “NY99-like” WNV strains would be 233 
transmitted more efficiently in a mosquito-bird cycle than the strains circulating in Europe in recent 234 
years. This may provide a suitable explanation for the epidemic spread and extensive wild bird 235 
mortality observed in North America, in comparison to Europe. Even though North American WNV 236 
isolates do not appear to be intrinsically more virulent than the European strains, at least for the 237 
house sparrow, they are likely more transmissible, leading to a more exacerbated cycle, a greater 238 
basic reproductive ratio (R0) and more infection events. Although an increased transmissibility does 239 
not necessarily mean a higher mortality, for WNV strains similar to NY99, which cause certain 240 
levels of mortality in house sparrows and other birds, it is likely, as the number of infections grows, 241 
the observed number of birds dying as a consequence of WNV disease would also increase. 242 
In this study, the house sparrow has been confirmed to be a suitable model for estimating key 243 
parameters of WNV infection in the avian host, and how they differ between different virus strains. 244 
It would be interesting to apply this model to the study of newly emerging WNV variants, such as 245 
those involved in the recent outbreaks of human West Nile neuroinvasive disease in Europe. 246 
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Table legends 344 
 345 
Table 1. Host competence index for each group of house sparrows. Competence index is 346 
determined by susceptibility (s), infectiousness (proportion of vectors that could become infected 347 
per day) (i) and duration of transmissible viraemia (d). The equation to calculate competence index 348 
is Ci = s x i x d. Host competence index (Ci) is a value that reflects the relative number of infectious 349 
mosquitoes that would be derived from feeding these hosts. 350 
 351 
Table 2. Viral genome load in house sparrow tissues at different days post inoculation. Each 352 
tissue was analyzed by semi-quantitative real time RT-PCR and the viral load is shown as the Ct 353 
value. Except bird #22 that died during manipulation (bleeding), all others were subjected to 354 
programmed necropsies. 355 
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Figure legends 358 
 359 
Figure 1. Mean daily blood viral genome (left panel) and viraemia titers (right panel), plotted for 360 
two groups of eight house sparrow either inoculated with WNV strain NY99 (open squares) or 361 
WNV strain Austria/2008 (closed circles). Error bars represent the standard error of the data. The 362 
efficiency of the semi-quantitative real-time RT-PCR for viral genome load determinations was E = 363 
0.908. 364 
 365 
Figure 2. Viral genome shedding through the oral (upper panel) and faecal (lower panel) routes as 366 
estimated by real-time RT-PCR analysis of the oropharyngeal and cloacal swabs, respectively, taken 367 
at different days post-inoculation of: WNV NY99 strain (white bars) and WNV strain Austria/2008 368 
(black bars). Error bars represent standard error of the data. Over each bar, nº of positive/examined 369 
swab samples are indicated.  370 
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